N. Panza

718 total citations
45 papers, 563 citations indexed

About

N. Panza is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, N. Panza has authored 45 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in N. Panza's work include Lung Cancer Research Studies (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer Treatment and Pharmacology (9 papers). N. Panza is often cited by papers focused on Lung Cancer Research Studies (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer Treatment and Pharmacology (9 papers). N. Panza collaborates with scholars based in Italy and United States. N. Panza's co-authors include Gaetano Lombardi, P. Comella, G. Frasci, Bernadette Biondi, Carlo Carella, G. Comella, G.P. Nicolella, R Cioffi, Luigi Saccà and Antonio Cittadini and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, British Journal of Cancer and Annals of Oncology.

In The Last Decade

N. Panza

44 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Panza Italy 14 250 204 167 137 77 45 563
Yukihiko Ohishi Japan 11 72 0.3× 180 0.9× 95 0.6× 107 0.8× 46 0.6× 51 448
Marjory Alana Marcello Brazil 15 261 1.0× 108 0.5× 435 2.6× 141 1.0× 64 0.8× 24 685
N. Eche France 11 113 0.5× 61 0.3× 51 0.3× 71 0.5× 40 0.5× 25 361
Masaki Shimbo Japan 14 113 0.5× 484 2.4× 169 1.0× 162 1.2× 25 0.3× 51 672
Louis‐Joseph Auguste United States 10 177 0.7× 123 0.6× 113 0.7× 40 0.3× 34 0.4× 19 478
S T O’Dwyer United Kingdom 11 215 0.9× 92 0.5× 146 0.9× 149 1.1× 68 0.9× 18 554
Mustafa Yaylacı Türkiye 10 187 0.7× 49 0.2× 98 0.6× 49 0.4× 35 0.5× 28 413
Tetsuya Urasaki Japan 12 205 0.8× 107 0.5× 55 0.3× 73 0.5× 41 0.5× 53 416
M Izuo Japan 12 175 0.7× 55 0.3× 66 0.4× 50 0.4× 34 0.4× 82 425
Kazumi Noguchi Japan 12 110 0.4× 235 1.2× 91 0.5× 90 0.7× 10 0.1× 58 485

Countries citing papers authored by N. Panza

Since Specialization
Citations

This map shows the geographic impact of N. Panza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Panza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Panza more than expected).

Fields of papers citing papers by N. Panza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Panza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Panza. The network helps show where N. Panza may publish in the future.

Co-authorship network of co-authors of N. Panza

This figure shows the co-authorship network connecting the top 25 collaborators of N. Panza. A scholar is included among the top collaborators of N. Panza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Panza. N. Panza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panza, N., Claudia Bianchini, Valentina Cetica, et al.. (2023). Bilateral temporal lobe dysplasia and seizure onset associated with biallelic CNTNAP2 variants. Epilepsia Open. 9(1). 417–423. 2 indexed citations
2.
Comella, P., G. Frasci, B. Massidda, et al.. (2004). Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients. British Journal of Cancer. 91(3). 489–497. 54 indexed citations
3.
Lorusso, Vito, E. Crucitta, N. Panza, et al.. (2002). Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer. Annals of Oncology. 13(12). 1862–1867. 4 indexed citations
4.
Colao, Annamaria, Diego Ferone, Paolo Marzullo, et al.. (2002). Lymphocyte subset pattern in acromegaly. Journal of Endocrinological Investigation. 25(2). 125–128. 18 indexed citations
5.
Santo, Antonio, Rebecca Pedersini, Felice Pasini, et al.. (2001). A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis. Lung Cancer. 34. 15–20. 13 indexed citations
6.
Frasci, G., G.P. Nicolella, P. Comella, et al.. (2001). A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study. British Journal of Cancer. 84(9). 1166–1171. 24 indexed citations
7.
Panza, N., Pier Francesco Rambaldi, Claudia Battista, et al.. (1999). Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumors. Biomedicine & Pharmacotherapy. 53(7). 319–322. 4 indexed citations
8.
Frasci, G., N. Panza, P. Comella, et al.. (1999). Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study. Annals of Oncology. 10(3). 355–358. 35 indexed citations
9.
Panza, N., G. Frasci, P. Comella, et al.. (1999). Cisplatin — Paclitaxel — Topotecan (CPT) weekly administration in chemo-naive or pretreated extensive disease small cell lung cancer (ED-SCLC). A SICOG Phase II study. European Journal of Cancer. 35. S252–S252. 4 indexed citations
10.
Frasci, G., P. Comella, N. Panza, et al.. (1998). Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients. European Journal of Cancer. 34(11). 1710–1714. 20 indexed citations
11.
Mansi, Luigi, et al.. (1997). Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid. European Journal of Endocrinology. 137(6). 688–690. 29 indexed citations
12.
Comella, P., G. Frasci, N. Panza, et al.. (1996). Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. British Journal of Cancer. 74(11). 1805–1811. 35 indexed citations
13.
Panza, N., Bartolomeo Merola, Annamaria Colao, et al.. (1996). Langerhans cell histiocytosis, diabetes insipidus, hyperprolactinemia and empty sella: A four-fold association. Report of two cases. Journal of Endocrinological Investigation. 19(1). 43–47. 2 indexed citations
14.
Fazio, Sergio, Bernadette Biondi, Carlo Carella, et al.. (1995). Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade.. The Journal of Clinical Endocrinology & Metabolism. 80(7). 2222–2226. 84 indexed citations
15.
Merola, Bartolomeo, Francesca Sarnacchiaro, Annamaria Colao, et al.. (1994). CV 205–502 in the treatment of tumoral and non-tumoral hyperprolactinemic states. Biomedicine & Pharmacotherapy. 48(3-4). 167–174. 4 indexed citations
16.
Battista, Claudia, N. Panza, Bruno Chiurazzi, et al.. (1993). Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM). Biomedicine & Pharmacotherapy. 47(4). 145–154. 1 indexed citations
17.
Lombardi, Gaetano, N. Panza, Bernadette Biondi, et al.. (1993). Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: A longitudinal study. Journal of Endocrinological Investigation. 16(4). 259–263. 33 indexed citations
18.
Rossi, Ryan A., A Tommaselli, N. Panza, et al.. (1992). Hormonal and immunological pattern in a patient with Acquired Immuno Deficiency Syndrome related complex and Cushing’s syndrome. Journal of Endocrinological Investigation. 15(11). 849–852. 1 indexed citations
19.
Mansi, Luigi, et al.. (1990). The biological approach to radioimmunoscitigraphy. Biomedicine & Pharmacotherapy. 44(6). 295–301. 1 indexed citations
20.
Lastoria, Secondo, Luigi Mansi, Giovanna Giordano, et al.. (1988). A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer. Nuclear Medicine Communications. 9(5). 347–356. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukihiko Ohishi Breakdown of academic impact, for papers by Marjory Alana Marcello Breakdown of academic impact, for papers by N. Eche Breakdown of academic impact, for papers by Masaki Shimbo Breakdown of academic impact, for papers by Louis‐Joseph Auguste Breakdown of academic impact, for papers by S T O’Dwyer Breakdown of academic impact, for papers by Mustafa Yaylacı Breakdown of academic impact, for papers by Tetsuya Urasaki Breakdown of academic impact, for papers by M Izuo Breakdown of academic impact, for papers by Kazumi Noguchi
Rankless by CCL
2026